799-6749790-0/11/1

AstraZeneca Pharmaceuticals LP — FEI 1825662

Refusal Details

Date
September 22, 2023
Country
United States
Product Category
Drugs and Biologics
Product Code
61PDA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75